DXB - Research & Valuation, page-67

Agree with you 100% @singhgu - I am in that self learning process for almost 20 years! Still learning and making mistakes.

The key to making money in the stock market is to identify those undervalued stocks - then control emotions and remain patient.

I used to rely heavily on HC comments but not anymore. We are all driven by our own selfish motives (including my own).

DXB is in a sweet spot - deals are signed and more deals to come. Recent price movements suggest that investors are slowly beginning to acknowledge the story here.

Compared to other similar biotechs, DXB is undervalued. DXB will likely get to 500m MC in the short to medium term IMHO.